Medication info
Nubirojet Tablet 80/2.5/5/10 mg

Nubirojet Tablet 80/2.5/5/10 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletRosuvastatin Calcium Micronized›5.2mg / 1 tabletS-Amlodipine Besylate Dihydrate›3.69mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202500657 · Approved 2025.03.21 · Insurance code 643309660

Summary

Main use
Treatment of hypertension and dyslipidemia (hypercholesterolemia, etc.)
Who takes it
Adults
Adult dose
This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/S-amlodipine (amlodipine) combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow this medicine whole without chewing, dividing, or crushing it. ○ Telmisartan/S-amlodipine (amlodipine) The recommended dose of the telmisartan/S-amlodipine (amlodipipine) combination is once daily. It is recommended that the dose be adjusted using the individual components (telmisartan or S-amlodipine [amlodipine]) before administering the telmisartan/S-amlodipine (amlodipine) combination. However, if blood pressure is not controlled with the individual components as follows, switching directly to the telmisartan/S-amlodipine (amlodipine) combination may be considered. - 40/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or telmisartan 40 milligrams. - 80/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with telmisartan 40 milligrams or 80 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with telmisartan 80 milligrams or this medicine 40/5 milligrams. ◦ Patients with hepatic impairment: The daily dose of telmisartan in patients with mild or moderate hepatic impairment should not exceed 40 milligrams. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin/ezetimibe Patients receiving the rosuvastatin/ezetimibe combination, whether before or during treatment, must continue a standard cholesterol-lowering diet. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg to 20/10mg once daily. The recommended initial dose is 5/10mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. Patients taking the telmisartan/S-amlodipine (amlodipine) combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Treatment of hypertension and dyslipidemia (hypercholesterolemia, etc.)

  • Essential hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used for patients who need to treat hypertension and dyslipidemia together. It is administered when controlling blood pressure with telmisartan and S-amlodipine monotherapy is inadequate. Additionally, it helps lower total cholesterol, LDL-cholesterol, Apo B protein, triglycerides, and increases HDL-cholesterol in patients with primary hypercholesterolemia or mixed dyslipidemia, as it contains rosuvastatin and ezetimibe. This medication is used to reduce the risk of cardiovascular diseases through effective improvement of blood pressure and blood lipid levels.

How to take

Adult dose

This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/S-amlodipine (amlodipine) combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow this medicine whole without chewing, dividing, or crushing it. ○ Telmisartan/S-amlodipine (amlodipine) The recommended dose of the telmisartan/S-amlodipine (amlodipipine) combination is once daily. It is recommended that the dose be adjusted using the individual components (telmisartan or S-amlodipine [amlodipine]) before administering the telmisartan/S-amlodipine (amlodipine) combination. However, if blood pressure is not controlled with the individual components as follows, switching directly to the telmisartan/S-amlodipine (amlodipine) combination may be considered. - 40/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or telmisartan 40 milligrams. - 80/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with telmisartan 40 milligrams or 80 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with telmisartan 80 milligrams or this medicine 40/5 milligrams. ◦ Patients with hepatic impairment: The daily dose of telmisartan in patients with mild or moderate hepatic impairment should not exceed 40 milligrams. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin/ezetimibe Patients receiving the rosuvastatin/ezetimibe combination, whether before or during treatment, must continue a standard cholesterol-lowering diet. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg to 20/10mg once daily. The recommended initial dose is 5/10mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. Patients taking the telmisartan/S-amlodipine (amlodipine) combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination containing the same amounts of each active ingredient) for convenience.

Precautions

This medication can cause serious harm to the fetus during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. If muscle pain or weakness occurs, immediate consultation with a doctor is advised, especially for patients with a history of muscle-related diseases or certain risk factors. Patients with impaired liver function or a history of liver disease must consult a doctor before taking this medication and undergo regular liver function tests while taking it. Patients with reduced kidney function are at risk for worsening kidney function when taking this medication, so kidney status should be regularly monitored through blood tests. Interactions may occur when taken with other medications, especially antihypertensives, anticoagulants, and fibrate medications, so patients should inform their doctor and manage carefully. This medication may lower blood pressure, which can lead to symptoms of hypotension such as dizziness and lightheadedness; caution is required when driving or operating machinery. Patients allergic to any ingredient in this medication or with specific genetic conditions should avoid its use. Possible adverse reactions include abnormalities in liver function, muscle pain, indigestion, headache, dizziness, etc., and if symptoms worsen or persist, immediate consultation with a doctor is necessary. Also, this medication contains certain dyes, so patients who exhibit hypersensitivity reactions should be careful. Finally, it is important to monitor liver, kidney, and muscle status regularly through blood tests and clinical checks during the course of this medication.

Side effects

Increased ALT, increased AST, increased Ɣ-GTP, edema, orthostatic hypotension, hyperkalemia, angioedema, elevated serum transaminases, impaired liver function, jaundice, hepatitis, toxic hepatitis, liver toxicity, interstitial lung disease, rhabdomyolysis, myalgia, weakness, elevated creatine kinase, headache, dizziness, cough, abdominal pain, diarrhea, dyspepsia, vomiting, dry mouth, altered taste, increased serum creatinine, increased blood uric acid, elevated serum creatine kinase (CK), reduced hemoglobin, angioedema, thrombocytopenia, anemia, thrombocytopenia, urticaria, rash, alopecia, dermatitis, skin burning sensation, diaphoresis, vasculitis, erectile dysfunction, insomnia, depression, anxiety, drowsiness, syncope, visual disturbances, vertigo, bradycardia, tachycardia, dyspnea, interstitial pneumonia, dizziness, sensory disturbances, paralysis, facial spasms, hypersomnia, neurodegenerative disorders, migraine, chest pain, strange sensation, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, hypersomnia, neurodegenerative disorders, petechiae, arthralgia, low back pain, muscle cramps, myopathy, myositis, musculoskeletal rigidity, musculoskeletal discomfort, muscle weakness, osteoarthritis, osteoporosis, skin disorders, erythema, maculopapular rash, sweating, purpura, toxic epidermal necrolysis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), morbilliform drug rash, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, chest pain, chest discomfort, weakness, generalized edema, tremors, epigastric pain, gastritis, discomfort in the epigastric region, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, diabetes, hypoglycemia, hyponatremia, increased blood pressure, elevated blood urea, increased CPK, abnormal liver function tests, erectile dysfunction, gynecomastia, increased urinary frequency, urinary disorders, nocturia, facial edema, ear discomfort, tinnitus, conjunctivitis, conjunctival hyperemia, headache, dizziness, nausea, constipation, loss of appetite, abdominal distention, syncope, generalized pain, gout, muscle cramps, palpitations, fatigue, nausea, insufficient effect

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent exposure to air and moisture and keep it at a temperature between 1°C and 30°C. This storage method helps maintain the medication's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.